{ "schemaVersion": 1, "organisationId": "O-c0e9b97368ff4debb4d610cb6fe3b083", "slug": "neogen-corp", "name": "NEOGEN CORP", "updatedAt": "2026-10-02T11:50:52.188937Z", "sections": [ { "type": "OVERVIEW", "text": "Neogen Corporation develops, manufactures, and markets products and services for food and animal safety. Its two core businesses are Food Safety, which provides diagnostic tests and related products and services, and Animal Safety, which includes veterinary, pharmaceutical, diagnostic, pest-control, and genomics offerings. [P145005052][P145005058][P145005654]\n\nThe company’s products are marketed worldwide through its sales personnel and distributors. Neogen states its mission is “to be the leading company in fueling a brighter future for global food and animal safety and security.” [P145005054] Formed in 1981, Neogen reported FY2026 net revenue of $870.4 million for the year ended May 31, 2026. [P145005055][T16582136]\n[P145005052][P145005058][P145005654][P145005054][P145005055][T16582136]", "updatedAt": "2026-10-02T11:50:52.188937Z" }, { "type": "PRODUCTS", "text": "Neogen’s food-safety products include diagnostic kits, consumables and culture media for detecting foodborne pathogens, spoilage organisms, toxins, allergens and other food-quality indicators. Its Molecular Detection System uses loop-mediated isothermal amplification (LAMP) to detect bacterial DNA; Reveal® uses lateral-flow immunoassay for qualitative testing; and Petrifilm® plates provide all-in-one systems for detecting and enumerating microorganisms. The portfolio also includes nucleic-acid and immunoassay tests, prepared media, and software for analyzing test results. [P145005058][P145005065][P145005066]\n\nNeogen Analytics is a software-as-a-service offering that aggregates and tracks environmental-monitoring, product-testing and sanitation-verification data. Animal-safety products include veterinary instruments and pharmaceuticals such as PanaKare, RenaKare, Uniprim, Provecta, BotVax B, EqStim and ImmunoRegulin; vaccines and topicals; and rodent- and insect-control products sold under brands including Ramik, CyKill, Havoc, Prozap, SureKill and StandGuard. The company also provides animal genomics services, including DNA genotyping, sequencing and trait analysis through six laboratories. [P145005068][P145005075][P145005076][P145005077]\n\nFor fiscal 2026, reported revenue was $870.4 million: $768.2 million from products and $102.2 million from services—approximately 88% and 12% of total revenue, respectively. Food Safety generated $641.1 million (about 74% of revenue) and Animal Safety $229.3 million (about 26%). Major reported categories included Indicator Testing/Culture Media ($332.7 million), Bacterial/General Sanitation ($175.4 million), and Animal Safety Genomics Services ($67.6 million). [T16543774][T16582100][T16543770]\n[P145005058][P145005065][P145005066][P145005068][P145005075][P145005076][P145005077][T16543774][T16582100][T16543770]", "updatedAt": "2026-10-02T11:50:52.188937Z" }, { "type": "GEOGRAPHY", "text": "Neogen’s headquarters are in Lansing, Michigan. It manufactures products in the United States, the United Kingdom, Ireland and Brazil, and provides genomics services in the United States, Scotland, Brazil, Australia, China and Canada. At May 31, 2026, about 1,257 employees were assigned to manufacturing operations and services across these locations; the reported figure is not broken down by country. [P145005055][P145005152]\n\nThe company describes administrative, sales, manufacturing and warehousing operations in domestic and international locations. Food-safety diagnostics manufacturing, final kit assembly, quality assurance and shipping take place at facilities in Michigan and Kentucky. [P145005423][P145005153]\n\nNeogen’s FY2025 regional revenue mix was reported as 55% United States and Canada, 16% Latin America, 14% Europe/Middle East/Africa, 12% Asia Pacific, and 3% Australia/New Zealand. These figures are for FY2025, and the United States and Canada are reported together. [https://www.sec.gov/Archives/edgar/data/711377/000095017025114388/neogen_fy25_annual_repor.pdf]\n[P145005055][P145005152][P145005423][P145005153][https://www.sec.gov/Archives/edgar/data/711377/000095017025114388/neogen_fy25_annual_repor.pdf]", "updatedAt": "2026-10-02T11:50:52.188937Z" }, { "type": "SEGMENTS", "text": "Neogen reports two business segments: **Food Safety** and **Animal Safety**. Food Safety provides diagnostic solutions, test kits, consumables, culture media and related products used by food and feed producers, processors, laboratories and regulators to detect or manage pathogens, spoilage, toxins, allergens and sanitation risks, and to assess certain food-quality and nutritional attributes. In FY2026, the segment generated $641.1 million in net revenue, approximately **73.7%** of consolidated revenue. [P145005052][P145005058][T16582136]\n\nAnimal Safety serves the worldwide animal-safety market with veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostics, rodent and insect control, and genomics testing. Its customers and channels include veterinarians, retailers, livestock producers and distributors; drug-detection products also serve workplace testing and human-forensic markets. In FY2026, it generated $229.3 million in net revenue, approximately **26.3%** of consolidated revenue. The percentages are calculated from segment net revenue after intersegment eliminations and total consolidated revenue of $870.4 million. The company identifies Food Safety and Animal Safety as its reportable segments. [P145005053][P145005058][P145005974][T16582136]\n[P145005052][P145005058][T16582136][P145005053][P145005974]", "updatedAt": "2026-10-02T11:50:52.188937Z" }, { "type": "HISTORY", "text": "Neogen was incorporated in Michigan in June 1981 and began operating in 1982, with founder James L. Herbert initially its sole employee. Herbert became CEO and chairman in 2006 and stepped down as CEO in 2017, when John Adent took the role. [P145005055][https://www.neogen.com/48d829/globalassets/pdfs/annual-reports/annual-report-2017.pdf][P185426737]\n\nThe company expanded through acquisitions, including culture-media business Acumedia in 2000 and genetics-testing company GeneSeek in 2010. In 2021 it acquired Genetic Veterinary Sciences, adding companion-animal genetic testing. [https://www.neogen.com/49346a/globalassets/pdfs/annual-reports/annual-report-2018.pdf][https://www.prnewswire.com/news-releases/neogen-acquires-geneseek-inc-89678072.html][https://investors.neogen.com/news/news-details/2021/Neogen-Acquires-Genetic-Veterinary-Sciences-Inc--DBA-Paw-Print-Genetics-12-09-2021/default.aspx]\n\nOn September 1, 2022, Neogen completed a transaction combining 3M’s Food Safety Division with the company, a major expansion of its food-safety business. Mike Nassif became CEO and president in August 2025. [P29636358][https://investors.neogen.com/news/news-details/2022/Neogen-Completes-3M-Food-Safety-Business-Merger-09-01-2022/default.aspx][https://investors.neogen.com/news/news-details/2025/Neogen-Corporation-Announces-Appointment-of-Mike-Nassif-as-CEO-and-President/default.aspx]\n[https://www.neogen.com/48d829/globalassets/pdfs/annual-reports/annual-report-2017.pdf][https://www.neogen.com/49346a/globalassets/pdfs/annual-reports/annual-report-2018.pdf][https://www.prnewswire.com/news-releases/neogen-acquires-geneseek-inc-89678072.html][https://investors.neogen.com/news/news-details/2021/Neogen-Acquires-Genetic-Veterinary-Sciences-Inc--DBA-Paw-Print-Genetics-12-09-2021/default.aspx][https://investors.neogen.com/news/news-details/2022/Neogen-Completes-3M-Food-Safety-Business-Merger-09-01-2022/default.aspx][https://investors.neogen.com/news/news-details/2025/Neogen-Corporation-Announces-Appointment-of-Mike-Nassif-as-CEO-and-President/default.aspx]", "updatedAt": "2026-10-02T11:50:52.188937Z" } ], "sources": [ { "id": "P145005052", "href": "https://app.finbar.com/go?id=P145005052", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005058", "href": "https://app.finbar.com/go?id=P145005058", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005654", "href": "https://app.finbar.com/go?id=P145005654", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005054", "href": "https://app.finbar.com/go?id=P145005054", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005055", "href": "https://app.finbar.com/go?id=P145005055", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "T16582136", "href": "https://app.finbar.com/go?id=T16582136", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005065", "href": "https://app.finbar.com/go?id=P145005065", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005066", "href": "https://app.finbar.com/go?id=P145005066", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005068", "href": "https://app.finbar.com/go?id=P145005068", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005075", "href": "https://app.finbar.com/go?id=P145005075", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005076", "href": "https://app.finbar.com/go?id=P145005076", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005077", "href": "https://app.finbar.com/go?id=P145005077", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "T16543774", "href": "https://app.finbar.com/go?id=T16543774", "label": "NEOGEN CORP — Press release (2026 Y)", "documentId": "D-28b20265ffd641068a667e4116c2f3aa" }, { "id": "T16582100", "href": "https://app.finbar.com/go?id=T16582100", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "T16543770", "href": "https://app.finbar.com/go?id=T16543770", "label": "NEOGEN CORP — Press release (2026 Y)", "documentId": "D-28b20265ffd641068a667e4116c2f3aa" }, { "id": "P145005152", "href": "https://app.finbar.com/go?id=P145005152", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005423", "href": "https://app.finbar.com/go?id=P145005423", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005153", "href": "https://app.finbar.com/go?id=P145005153", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "https://www.sec.gov/Archives/edgar/data/711377/000095017025114388/neogen_fy25_annual_repor.pdf", "href": "https://www.sec.gov/Archives/edgar/data/711377/000095017025114388/neogen_fy25_annual_repor.pdf", "label": "www.sec.gov" }, { "id": "P145005053", "href": "https://app.finbar.com/go?id=P145005053", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "P145005974", "href": "https://app.finbar.com/go?id=P145005974", "label": "NEOGEN CORP — Full financial report (2026 Y)", "documentId": "D-2a83e7e16fde40d997764f9b2d5f301c" }, { "id": "https://www.neogen.com/48d829/globalassets/pdfs/annual-reports/annual-report-2017.pdf", "href": "https://www.neogen.com/48d829/globalassets/pdfs/annual-reports/annual-report-2017.pdf", "label": "www.neogen.com" }, { "id": "P185426737", "href": "https://app.finbar.com/go?id=P185426737", "label": "NEOGEN CORP — Full financial report (2017 Y)", "documentId": "D-708c3aa63d964d8e96c5fd7c92931647" }, { "id": "https://www.neogen.com/49346a/globalassets/pdfs/annual-reports/annual-report-2018.pdf", "href": "https://www.neogen.com/49346a/globalassets/pdfs/annual-reports/annual-report-2018.pdf", "label": "www.neogen.com" }, { "id": "https://www.prnewswire.com/news-releases/neogen-acquires-geneseek-inc-89678072.html", "href": "https://www.prnewswire.com/news-releases/neogen-acquires-geneseek-inc-89678072.html", "label": "www.prnewswire.com" }, { "id": "https://investors.neogen.com/news/news-details/2021/Neogen-Acquires-Genetic-Veterinary-Sciences-Inc--DBA-Paw-Print-Genetics-12-09-2021/default.aspx", "href": "https://investors.neogen.com/news/news-details/2021/Neogen-Acquires-Genetic-Veterinary-Sciences-Inc--DBA-Paw-Print-Genetics-12-09-2021/default.aspx", "label": "investors.neogen.com" }, { "id": "P29636358", "href": "https://app.finbar.com/go?id=P29636358", "label": "NEOGEN CORP — Full financial report (2025 Y)", "documentId": "D-4da852fb4ef94a44b0acbdbab22be654" }, { "id": "https://investors.neogen.com/news/news-details/2022/Neogen-Completes-3M-Food-Safety-Business-Merger-09-01-2022/default.aspx", "href": "https://investors.neogen.com/news/news-details/2022/Neogen-Completes-3M-Food-Safety-Business-Merger-09-01-2022/default.aspx", "label": "investors.neogen.com" }, { "id": "https://investors.neogen.com/news/news-details/2025/Neogen-Corporation-Announces-Appointment-of-Mike-Nassif-as-CEO-and-President/default.aspx", "href": "https://investors.neogen.com/news/news-details/2025/Neogen-Corporation-Announces-Appointment-of-Mike-Nassif-as-CEO-and-President/default.aspx", "label": "investors.neogen.com" } ] }